EVM
QTTB icon

Eaton Vance Management’s Q32 Bio QTTB Stock Holding History

Eaton Vance Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7
Closed – – 2760
2021
Q4 		$0 Sell
7
-44
-86% -$4.27K ﹤0.01% 2891
2021
Q3 		$7K Hold
51
– – ﹤0.01% 1768
2021
Q2 		$7K Sell
51
-45
-47% -$5.62K ﹤0.01% 2602
2021
Q1 		$16K Buy
+96
New +$20.2K ﹤0.01% 2186

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Eaton Vance Management's QTTB Position: Q1 2022 in Review

Eaton Vance Management sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 7 shares.

Eaton Vance Management first reported a position in QTTB in Q1 2021 and held it in 4 quarters. The position peaked at $16K in Q1 2021. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • Eaton Vance Management reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 7 Q32 Bio shares in Q1 2022.
  • Eaton Vance Management first reported a position in Q32 Bio in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Q32 Bio position peaked at $16K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.